WAND.L $1 310.00 0%
KGC $5.31 -0.469%
MLOSA.PA $1.46 0%
0IHP.L $107.22 -0.4549%
RXRX $5.19 -3.9815%
SEE.L $5.70 0%
RITM $7.91 0%
IVA.PA $2.40 0.6302%
VEVE.L $65.47 0.2373%
0712.HK $0.12 5.9829%
AET.L $26.65 -0.9294%
CIX $18.91 1.2313%
6183.HK $0.08 0%
ROQ.L $6.75 0%
2363.HK $0.08 -2.5974%
PIFI $93.01 -0.1396%
ALDEL.PA $51.20 -1.1583%
0763.HK $22.45 -1.7505%
BRPMU $13.45 0%
MLSML.PA $0.02 0%
0525.HK $2.03 -1.9324%
INKT $1.69 4.321%
ASIT.L $71.20 0.8499%
SMFR $0.31 -22.3694%
MAFL.L $21.50 2.381%
8128.HK $0.03 0%
IPRP.L $2 089.50 -1.578%
CPLE3.SA $6.96 -0.5714%
0718.HK $0.05 -5.5556%
SMLR $29.98 9.8169%
SNOA $1.00 -1.4752%
PCPC $25.09 0%
KSMT $10.49 0%
OYST $11.17 0%
DGLY $3.24 -0.3077%
SMAR.BR $29.40 0%
2688.HK $109.20 -2.587%
PR1T.L $20.47 0.0611%
0DTF.L $39.20 0.3841%
DAVA $48.95 -3.4996%
CKN.L $2 995.00 0.335%
JPEH.L $48.87 0%
CNHI $14.01 1.1922%
ISJP.L $3 132.00 0.9671%
GLO.PA $22.00 2.5641%
DHF $2.16 -0.9174%
RNMC $26.51 -0.6744%
AUAD.L $1 777.00 0.7227%
0L8U.L $15.54 -0.0225%
0QT0.L $27.25 -2.9831%
0GX2.L $37.20 0.2695%
QDIV.L $40.52 0.1258%
PRIJ.L $2 090.75 0.9476%
ENTR $10.91 0.2204%
NEW $1.36 0%
EXK $3.40 -1.4493%
ARI $9.56 -0.6237%
CSUS.L $409.95 -0.168%
0OCQ.L $1.80 1.8079%
SNDA $6.50 -2.9851%
ENI.BR $13.69 0%
XPEV $9.90 -7.907%
AHG $0.32 -6.6219%
BGCG.L $227.00 -1.5184%
SECN.L $111.00 0%
ALVO $9.76 4.4968%
2007.HK $1.88 -3.0928%
0RQI.L $7.77 0.5073%
0766.HK $0.04 0%
FAX $2.70 -0.369%
MSED.PA $230.55 0.3701%
REVS $19.74 -0.1118%
FNCN3.SA $14.25 0%
PGF $13.95 0.2811%
FXB $119.81 -0.2997%
BLC.PA $29.70 -0.6689%
0601.HK $0.15 8.4507%
RMM $15.38 -0.5104%
6868.HK $4.65 -0.8529%
BGIO $2.63 0%
1742.HK $0.06 -3.3898%
0HC2.L $51.12 11.5305%
AFP.L $2.72 -4.7368%
RAAC $9.30 0%
CFA $67.34 -0.4338%
AMPG $2.81 -4.7458%
1853.HK $1.98 0%
0L7S.L $300.07 1.2792%
GREEN.BR $6.44 -2.4242%
0085.HK $1.18 -3.2787%
1280.HK $0.76 -22.449%
WOLF $39.94 1.1525%
ARDC $11.97 -0.416%
HDD.L $13.75 1.8519%
GID.PA $0.80 0%
PYPL $61.90 -3.5759%
AAON $94.16 -1.7016%
6138.HK $0.26 -1.9231%
8045.HK $0.15 0%
ARKF $18.22 -2.9051%
Eng
Логотип
Eng
Лого

Shield Therapeutics plc STX.L

$7.55

На 18:02, 12 мая 2023

Ключевые показатели

  • Marketcap

    45389426.00000000

  • week52high

    16.75

  • week52low

    5.52

  • Revenue

    4467000

  • P/E TTM

    0

  • Beta

    0.79923600

  • EPS

    -0.08000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    27 апр 2023 г. в 15:30

Описание компании

Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек